Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Smith

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
British Journal of Haematology|August 26, 2010
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphomaJorge E Romaguera, Luis E Fayad, Peter McLaughlin, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2015
Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory BoardBrian R Lane, Jeffrey Bissonnette, Tracy Waldherr, et al.
Plos One|January 27, 2022
Consumer engagement in health care policy, research and services: A systematic review and meta-analysis of methods and effectsLouise K Wiles, Debra Kay, Julie A Luker, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of colorCarla Cerami, Tyler Rapp, Feng-Chang Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2021
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States: Living Density, Viral Load, and Disproportionate Impact on Communities of ColorCarla Cerami, Zachary R Popkin-Hall, Tyler Rapp, et al.
Cancer|May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphomaJorge E Romaguera, Michael Wang, Lei Feng, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 13, 2019
Clinical management practices of life-threatening asthma: an audit of practices in intensive carePaul Secombe, Penny Stewart, Sunil Singh, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
British Journal of Haematology|August 26, 2010
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphomaJorge E Romaguera, Luis E Fayad, Peter McLaughlin, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2015
Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory BoardBrian R Lane, Jeffrey Bissonnette, Tracy Waldherr, et al.
Plos One|January 27, 2022
Consumer engagement in health care policy, research and services: A systematic review and meta-analysis of methods and effectsLouise K Wiles, Debra Kay, Julie A Luker, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of colorCarla Cerami, Tyler Rapp, Feng-Chang Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2021
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States: Living Density, Viral Load, and Disproportionate Impact on Communities of ColorCarla Cerami, Zachary R Popkin-Hall, Tyler Rapp, et al.
Cancer|May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphomaJorge E Romaguera, Michael Wang, Lei Feng, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 13, 2019
Clinical management practices of life-threatening asthma: an audit of practices in intensive carePaul Secombe, Penny Stewart, Sunil Singh, et al.
Pageof 4